Key statistics
As of last trade, Atara Biotherapeutics Inc (ATRA:NSQ) traded at 7.89, 58.91% above the 52 week low of 4.97 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.87 |
---|---|
High | 7.89 |
Low | 7.54 |
Bid | 7.82 |
Offer | 7.89 |
Previous close | 7.79 |
Average volume | 116.73k |
---|---|
Shares outstanding | 5.66m |
Free float | 4.41m |
P/E (TTM) | -- |
Market cap | 44.12m USD |
EPS (TTM) | -39.90 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 15:26 BST.
More ▼
- Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Atara Biotherapeutics Announces $36 Million Registered Direct Offering
- Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update
- Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
- Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
More ▼